002424 fundamentals
Key facts
Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. It offers medicines in the form of tablets, capsules, syrups, soft capsules, granules, pills, powder, sprays, creams, and injections. Its products are used for the treatment of cardiovascular and cerebrovascular diseases, cough, common cold, and fever. The company was founded on March 25, 1999 and is headquartered in Anshun, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company